HBV and HCV infections in heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 20, Issue 7, 2001, Pages 718-724

  Fagiuoli, Stefano ^a,d   Minniti, Francesco ^a   Pevere, Sara ^a   Farinati, Fabio ^a   Burra, Patrizia ^a   Livi, Ugolino ^b   Naccarato, Remo ^a   Chiaramonte, Maria ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DONOR; FEMALE; GRAFT REJECTION; HEART GRAFT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SERODIAGNOSIS; VIRUS INFECTION; VIRUS REPLICATION;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS ANTIGENS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; ITALY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VIRAL HEPATITIS VACCINES;

EID: 0034940129     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00255-8     Document Type: Article

References (37)

1. Transmission of hepatitis C virus by organ transplantation
2. Hepatitis C virus infection in the immunocompromised patient
3. Chronic liver dysfunction in heart transplant recipients, with special reference to viral B, C and non-A, non-B, non-C hepatitis
4. Anti hepatitis C virus (HCV) antibodies in heart transplant recipients with post-transplantation chronic viral non-A non-B hepatitis
5. Hepatitis virus infection in heart transplant recipients
6. Hepatitis C status of heart transplant recipients
7. Outcome of de novo hepatitis C virus infection in heart transplant recipients
8. Serologic responses to hepatitis C virus in solid organ transplant recipients
9. Long-term follow-up of hepatitis C virus infection among organ transplant recipients; implications for policies on organ procurement
10. Prevalence of hepatitis C infection among heart transplant recipients
11. Long-term outcome of chronic hepatitis B in heart transplant recipients
12. Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy
13. Epidemiology of hepatitis C
14. Prevalence of chronic liver disease in the general population of Northern Italy; the Dyonisus Study
15. High prevalence of hepatitis C virus infection in a small central Italian town; lack of evidence of parenteral exposure
16. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population. A community-based survey in Southern Italy
17. Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase reaction
18. FK-506 in liver transplantation for chronic hepatitis B; in vitro studies on lymphocyte activation and virus replication
19. Natural history of chronic hepatitis B virus infection; new light on an old story
20. Long-term patient and renal allograft survival in HBsAg infection; a recent update
21. Impact of HBs antigenemia on long-term patient survival and causes of death after renal transplantation
22. Hepatitis B liver disease in cyclosporin-treated renal allograft recipients
23. Hepatitis C virus in kidney recipients; epidemiology and impact on renal transplantation
24. Outcome of HCV virus infection after renal transplantation
25. The impact of hepatitis C virus infection on renal allograft recipients
26. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients
27. Impact on hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients; correlation with clinicopathological features
28. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
29. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus
30. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT; a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group
31. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers; a review of the problem
32. Liver transplantation for chronic viral liver disease
33. Liver transplantation in viral hepatitis. New insights
34. Viral hepatitis in the liver transplant recipient